The federal contract award is for the delivery of ENBREL 25 MG/0.5 ML VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $37,173.86 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 9, 2024. The contract has an ultimate completion date of October 10, 2024 and is not set aside for a specific business type. Amerisourcebergen, through its Corporate Office division, will supply these critical care medications to support military treatment facilities and other federal healthcare providers nationwide. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of pharmaceutical and medical supplies to the Department of Defense.
Generated 1/8/25, 9:18 AM